Recent Finacing
Recent Raise
Complement Therapeutics is a preclinical University of Manchester spinout developing CTx001, an AAV gene therapy for geographic atrophy, and a CPM platform quantifying 30+ complement proteins for diagnostics.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Complement Therapeutics.
